FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

BIORESTORATIVE THERAPIES, INC.: cashflow_financing

One fact, its scope and the complete path back to the official record.

Period: 2024-01-01 – 2024-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/b1944836-4f99-4b93-8849-e2ca7662ca7a

Reported value

$7.379M{"amount": 7379330, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Entity
BIORESTORATIVE THERAPIES, INC.
Metric
cashflow_financing
Period
2024-01-01 – 2024-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001641172-25-001011 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T15:05:09.424206+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001505497/cashflow-financing/2024-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.